Form SCHEDULE 13G Korro Bio, Inc. Filed by: Point72 Asset Management, L.P. Mar 11, 2026 05:25PM
Form SCHEDULE 13G/A Celldex Therapeutics, Filed by: Point72 Asset Management, L.P. Mar 10, 2026 06:42PM
Form SCHEDULE 13G Edesa Biotech, Inc. Filed by: Point72 Asset Management, L.P. Mar 3, 2026 04:29PM
reAlpha Tech appoints Thomas Kutzman as chief financial officer Feb 27, 2026 08:30AM
Form SCHEDULE 13G Beta Bionics, Inc. Filed by: Point72 Asset Management, L.P. Feb 23, 2026 06:10PM
View Older Stories

Feb 19, 2026 04:59PM Form SCHEDULE 13G Q32 Bio Inc. Filed by: Point72 Asset Management, L.P.
Feb 18, 2026 05:42PM Form SCHEDULE 13G OKYO Pharma Ltd Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:38PM Form SCHEDULE 13G/A Century Therapeutics, Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:37PM Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:37PM Form SCHEDULE 13G/A Kodiak Sciences Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:36PM Form SCHEDULE 13G/A WOLFSPEED, INC. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:36PM Form SCHEDULE 13G/A ADC Therapeutics SA Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:35PM Form SCHEDULE 13G/A Verastem, Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:35PM Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:35PM Form SCHEDULE 13G/A Confluent, Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:34PM Form SCHEDULE 13G/A Cidara Therapeutics, Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:34PM Form SCHEDULE 13G/A FG Nexus Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:33PM Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:33PM Form SCHEDULE 13G/A PagSeguro Digital Ltd. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:31PM Form SCHEDULE 13G/A Alto Neuroscience, Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:30PM Form SCHEDULE 13G/A Korro Bio, Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:29PM Form SCHEDULE 13G/A PLIANT THERAPEUTICS, Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:29PM Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:29PM Form SCHEDULE 13G/A Design Therapeutics, Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:29PM Form SCHEDULE 13G/A IDEAYA Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:28PM Form SCHEDULE 13G/A WOLVERINE WORLD WIDE Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:28PM Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:27PM Form SCHEDULE 13G/A Invivyd, Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:26PM Form SCHEDULE 13G/A Aptevo Therapeutics Inc. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:17PM Form 13F-HR Point72 Asset Management For: Dec 31
Feb 6, 2026 04:10PM Form SCHEDULE 13G IO Biotech, Inc. Filed by: Point72 Asset Management, L.P.
Jan 30, 2026 09:01AM NeOnc Technologies secures $16 million PIPE investment led by Cinctive
Jan 23, 2026 04:06PM Form SCHEDULE 13G PRECIGEN, INC. Filed by: Point72 Asset Management, L.P.
Jan 21, 2026 04:11PM Form SCHEDULE 13G Infinite Eagle Acquisiti Filed by: Point72 Asset Management, L.P.
Jan 20, 2026 04:52PM Form SCHEDULE 13G Forte Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
Jan 13, 2026 06:04PM Form SCHEDULE 13G/A KalVista Pharmaceuticals Filed by: Point72 Asset Management, L.P.
Jan 12, 2026 06:34PM Form SCHEDULE 13G KalVista Pharmaceuticals Filed by: Point72 Asset Management, L.P.
Jan 9, 2026 04:10PM Form SCHEDULE 13G VNET Group, Inc. Filed by: Point72 Asset Management, L.P.
Jan 5, 2026 04:13PM Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: Point72 Asset Management, L.P.
Jan 5, 2026 04:11PM Form SCHEDULE 13G Century Therapeutics, Filed by: Point72 Asset Management, L.P.
Dec 31, 2025 04:14PM Point72 reports 9.2% passive stake in Tonix Pharma (TNXP)
Dec 31, 2025 04:10PM Form SCHEDULE 13G Tonix Pharmaceuticals Filed by: Point72 Asset Management, L.P.
Dec 1, 2025 10:26AM Bally's Corporation (BALY) shares soar on NYC casino win
Dec 1, 2025 10:22AM Steve Cohen, Bally's, Genting Group to run NYC casinos
Nov 24, 2025 04:10PM Form SCHEDULE 13G BILL Holdings, Inc. Filed by: Point72 Asset Management, L.P.
Nov 19, 2025 08:30AM BitMine engages Tom DeMark as strategic advisor for ETH strategy
Nov 14, 2025 04:25PM Form 13F-HR Point72 Asset Management For: Sep 30
Nov 14, 2025 04:23PM Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
Nov 14, 2025 04:21PM Form SCHEDULE 13G/A CYBIN INC. Filed by: Point72 Asset Management, L.P.
Nov 14, 2025 04:20PM Form SCHEDULE 13G/A Confluent, Inc. Filed by: Point72 Asset Management, L.P.
Nov 14, 2025 04:18PM Form SCHEDULE 13G/A Turnstone Biologics Corp Filed by: Point72 Asset Management, L.P.
Nov 14, 2025 04:17PM Form SCHEDULE 13G/A PepGen Inc. Filed by: Point72 Asset Management, L.P.
Nov 14, 2025 04:17PM Form SCHEDULE 13G/A Mobileye Global Inc. Filed by: Point72 Asset Management, L.P.
Nov 14, 2025 04:16PM Form SCHEDULE 13G/A Cidara Therapeutics, Filed by: Point72 Asset Management, L.P.
Nov 14, 2025 04:16PM Form SCHEDULE 13G/A Replimune Group, Inc. Filed by: Point72 Asset Management, L.P.
View Older Stories